742 related articles for article (PubMed ID: 31884074)
1. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.
Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI
Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422
[TBL] [Abstract][Full Text] [Related]
3. Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1.
Chan YX; Alfonso H; Paul Chubb SA; Ho KKY; Gerard Fegan P; Hankey GJ; Golledge J; Flicker L; Yeap BB
Clin Endocrinol (Oxf); 2018 Feb; 88(2):333-340. PubMed ID: 29044573
[TBL] [Abstract][Full Text] [Related]
4. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.
Murphy N; Knuppel A; Papadimitriou N; Martin RM; Tsilidis KK; Smith-Byrne K; Fensom G; Perez-Cornago A; Travis RC; Key TJ; Gunter MJ
Ann Oncol; 2020 May; 31(5):641-649. PubMed ID: 32169310
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.
Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A;
Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1 and site-specific cancers: A Mendelian randomization study.
Larsson SC; Carter P; Vithayathil M; Kar S; Mason AM; Burgess S
Cancer Med; 2020 Sep; 9(18):6836-6842. PubMed ID: 32717139
[TBL] [Abstract][Full Text] [Related]
8. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
10. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study.
Adachi Y; Nojima M; Mori M; Himori R; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A;
Cancer Prev Res (Phila); 2020 Apr; 13(4):385-394. PubMed ID: 31996369
[TBL] [Abstract][Full Text] [Related]
12. Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors.
Adachi Y; Nojima M; Mori M; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A;
J Gastroenterol Hepatol; 2019 Dec; 34(12):2104-2111. PubMed ID: 31158304
[TBL] [Abstract][Full Text] [Related]
13. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
[TBL] [Abstract][Full Text] [Related]
14. Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk.
Tsai CW; Chang WS; Xu Y; Huang M; Bau DT; Gu J
Mol Carcinog; 2021 Nov; 60(11):726-733. PubMed ID: 34293213
[TBL] [Abstract][Full Text] [Related]
15. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.
Chen W; Wang S; Tian T; Bai J; Hu Z; Xu Y; Dong J; Chen F; Wang X; Shen H
Eur J Hum Genet; 2009 Dec; 17(12):1668-75. PubMed ID: 19491931
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
Cao Y; Lindström S; Schumacher F; Stevens VL; Albanes D; Berndt S; Boeing H; Bueno-de-Mesquita HB; Canzian F; Chamosa S; Chanock SJ; Diver WR; Gapstur SM; Gaziano JM; Giovannucci EL; Haiman CA; Henderson B; Johansson M; Le Marchand L; Palli D; Rosner B; Siddiq A; Stampfer M; Stram DO; Tamimi R; Travis RC; Trichopoulos D; Willett WC; Yeager M; Kraft P; Hsing AW; Pollak M; Lin X; Ma J
J Natl Cancer Inst; 2014 Jun; 106(6):dju085. PubMed ID: 24824313
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
; Key TJ; Appleby PN; Reeves GK; Roddam AW
Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501
[TBL] [Abstract][Full Text] [Related]
18. Association of lncRNA MEG3 rs941576 polymorphism, expression profile, and its related targets with the risk of obesity-related colorectal cancer: potential clinical insights.
Senousy MA; Shaker OG; Ayeldeen G; Radwan AF
Sci Rep; 2024 May; 14(1):10271. PubMed ID: 38704452
[TBL] [Abstract][Full Text] [Related]
19. Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses.
Dimou N; Mori N; Harlid S; Harbs J; Martin RM; Smith-Byrne K; Papadimitriou N; Bishop DT; Casey G; Colorado-Yohar SM; Cotterchio M; Cross AJ; Marchand LL; Lin Y; Offit K; Onland-Moret NC; Peters U; Potter JD; Rohan TE; Weiderpass E; Gunter MJ; Murphy N
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1336-1348. PubMed ID: 33879453
[TBL] [Abstract][Full Text] [Related]
20. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
